Fred Goldwater - Profile and Investment Details

Investor Profile

Fred Goldwater is a Venture Capital, Private Equity Firm, Investor based in Durham, North Carolina, United States with a diverse investment portfolio that includes companies such as Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience, Artizan Biosciences, MATI Energy, SpineAlign Medical, Lysosomal Therapeutics, Kymera Therapeutics, Spyryx Biosciences, Bivarus, AtaCor Medical, Jumo Health, Clinipace, StrideBioGrayBug, Nusirt, WalletFi, Ribometrix, Curoverse, Rodin Therapeutics, Medfusion, GeneCentric Diagnostics, Boragen, Myeloid Therapeutics, Trefoil Therapeutics, Empliant, G1 Therapeutics, ArtusLabs, Clinverse, Elligo Health Research, Atsena Therapeutics, PhaseBio Pharmaceuticals, HistoSonics, Boston Immune Technologies & Therapeutics, NeuroTronik, Altis Biosystems, Viamet Pharmaceuticals, Coferon, TetraLogic Pharmaceuticals, ORIG3N, 410 Medical, CVRx, Qpex Biopharma, Qvella Corporation, NurseGrid, Sideris Pharmaceuticals, Wildflower Health, Shattuck Labs, . Over time, Fred Goldwater has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Fred Goldwater is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Regenerative Medicine, Hospitals, Wellness, Women Founded, Android, Healthcare Innovation, Life Science, Medical Technologies, Information Technology (IT), Software, Biotechnology, Healthcare IT, Medical Devices, Drug Development, Electronic Health Records (EHR), Health and Hospital Services, Precision Medicine, Clinical Trials, Gene Therapy, Personalized Medicine, Medical Diagnostics, Health Diagnostics, Digital Health, Medical, B2B, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Fred Goldwater, as their portfolio suggests a familiarity and interest in this area.

Understanding Fred Goldwater’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.